Introduction
Overview of research publications about interventions to reduce transmission of leprosy: post-exposure prophylaxis (PEP), including SDR and enhanced chemoprophylaxis, contact management and cluster prophylaxis.
We welcome your suggestions: please send comments or suggested additions to info@infolep.org.
Related publications(s)
Publication
Effectiveness of single dose rifampicin after BCG-vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: a cluster randomized controlled trial.
Richardus R, Alam K, Kundu K, et al.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
2019;
Download PDF
Publication
An innovative approach to screening and chemoprophylaxis among contacts of leprosy patients in low endemic settings: experiences from Cambodia.
Cavaliero A, Greter H, Fürst T, et al.
PLoS neglected tropical diseases.
2019;
13 (3) : e0007039.
Download PDF
Publication
An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++.
Mieras L, Taal AT, van Brakel WH, et al.
BMC infectious diseases.
2018;
18 (1) : 506.
Download PDF
Publication
Chemoprophylaxis of leprosy with rifampicin in contacts of multibacillary patients: study protocol for a randomized controlled trial.
Dos Santos DS, Duppre NC, Sarno EN, et al.
Trials.
2018;
19 (1) : 244.
Download PDF
Publication
Innovative tools and approaches to end the transmission of Mycobacterium leprae.
Steinmann P, Reed SG, Mirza F, et al.
The Lancet. Infectious diseases.
2017;
Download PDF
Publication
Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy.
Duthie MS, Balagon MF.
Risk management and healthcare policy.
2016;
Download PDF
Publication
Protecting people against leprosy: Chemoprophylaxis and immunoprophylaxis.
Richardus JH, Oskam L.
Clinics in Dermatology.
2015;
33 (1) : 19 - 25.
Publication
Cost-effectiveness of a chemoprophylactic intervention with single dose rifampicin in contacts of new leprosy patients.
Idema WJ, Majer IM, Pahan D, et al.
PLoS neglected tropical diseases.
2010;
4 (11) : e874.
Download PDF
Publication
Chemoprophylaxis in contacts of patients with leprosy: systematic review and meta-analysis.
Reveiz L, Buendía JA, Téllez D.
Revista panamericana de salud publica = Pan American journal of public health.
2009;
26 (4) : 341-9.
Download PDF
Publication
Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial.
Moet JF, Pahan D, Oskam L, et al.
British medical journal.
2008;
336 (7647) : 761-4.
Download PDF
Publication
Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. MILEP2 Study Group. Mucosal Immunology of Leprosy.
Smith C M, Smith W C.
The Journal of infection.
2000;
41 (2) : 137-42.
Publication
Chemoprophylaxis for contacts of leprosy patients: A systematic review and meta-analysis
Ferreira A, Fan W, Agarwal A, et al.
Indian journal of leprosy.
2018;
Download PDF
Publication
Effectiveness of rifampicin chemoprophylaxis in preventing leprosy in patient contacts: a systematic review of quantitative and qualitative evidence.
Ferreira SMB, Yonekura T, Ignotti E, et al.
JBI database of systematic reviews and implementation reports.
2017;
15 (10) : 2555-2584.
Publication
Global practices in regard to implementation of preventive measures for leprosy.
Gillini L, Cooreman E, Wood T, et al.
PLoS neglected tropical diseases.
2017;
11 (5) : e0005399.
Download PDF
Publication
Chemoprophylaxis: sufficient evidence for starting implementation pilots
Richardus JH.
Leprosy review.
2015;
Download PDF
Publication
Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia.
Tiwari A, Dandel S, Djupuri R, et al.
BMC infectious diseases.
2018;
18 (1) : 324.
Download PDF
Publication
A single dose of rifampicin to prevent leprosy: qualitative analysis of perceptions of people affected, contacts, community members and health professionals towards chemoprophylaxis and the impact on their attitudes in India, Nepal and Indonesia
Peters R, Mieras L, Subedi M, et al.
Leprosy review.
2018;
89 (4) : 335-352.
Download PDF